Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | LN0591 | LA |
body aches; migraine; fever; nausea; exhaustion; This is a spontaneous report received from a Consumer or other non HCP. A 27-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 09Feb2025 at 15:45 as dose 1, single (Lot number: LN0591) at the age of 27 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LO LOESTRIN FE, start date: Apr2015; SPIRONOLACTONE, start date: Jan2015. The following information was reported: PAIN (non-serious) with onset 09Feb2025 at 23:45, outcome "recovered" (12Feb2025), described as "body aches"; FATIGUE (non-serious) with onset 09Feb2025 at 23:45, outcome "recovered" (12Feb2025), described as "exhaustion"; PYREXIA (non-serious) with onset 09Feb2025 at 23:45, outcome "recovered" (12Feb2025), described as "fever"; MIGRAINE (non-serious) with onset 09Feb2025 at 23:45, outcome "recovered" (12Feb2025); NAUSEA (non-serious) with onset 09Feb2025 at 23:45, outcome "recovered" (12Feb2025). Therapeutic measures were not taken as a result of pain, migraine, pyrexia, nausea, fatigue. Additional information: The patient did not receive any other vaccines on the same date as the vaccine(s). The patient did not receive any other vaccines within 4 weeks PRIOR to the vaccine(s).
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
LO LOESTRIN FE; SPIRONOLACTONE